© 1999 American Heart Association, Inc.
Original Contributions |
Dietary 
-3, -6, and -9 Unsaturated Fatty Acids and Growth Factor and Cytokine Gene Expression in Unstimulated and Stimulated Monocytes
A Randomized Volunteer Study
From Medizinische Klinik, Klinikum Innenstadt, University of Munich, Munich, Germany.
Correspondence to Clemens von Schacky, MD, Medizinische Klinik, Klinikum Innenstadt, Universität München, Ziemssenstr 1, D-80336 Munich, Munich, Germany. E-mail vonschacky{at}medinn.med.uni-muenchen.de
Abstract—Dietary 
-3
fatty acids retard coronary atherosclerosis.
Previously, we demonstrated that dietary -3 fatty acids reduce
platelet-derived growth factor (PDGF)-A and PDGF-B mRNA levels in
unstimulated, human mononuclear cells (MNCs). In a randomized,
investigator-blinded intervention trial, we have now compared the
effect of ingestion of 7 g/d -3, -6, or -9 fatty acids for 4
weeks versus no dietary intervention on PDGF-A, PDGF-B, heparin-bound
epidermal growth factor (HB-EGF), monocyte chemoattractant protein-1
(MCP-1), and interleukin-10 gene expression in unstimulated MNCs and in
monocytes that were adherence-activated ex vivo in a total of
28 volunteers. In unstimulated MNCs, mRNA steady-state levels of
PDGF-A, PDGF-B, and MCP-1 were reduced by 25±10%, 31±13%, and
40±14%, respectively, after -3 fatty acid ingestion, as assessed
by quantitative polymerase chain reaction (all P<0.05).
In monocytes that were adherence-activated ex vivo for 4 and 20
hours, mRNA steady-state levels of PDGF-A, PDGF-B, and MCP-1 were
reduced by 25±13%, 20±15%, and 30±8%, respectively (all
P<0.05). Interleukin-10 and HB-EGF mRNA steady-state
levels were not influenced by -3 fatty acid ingestion. Expression of
all respective mRNAs in control volunteers or in those ingesting -6
or -9 fatty acids were not altered. We conclude that human gene
expression for PDGF-A, PDGF-B, and MCP-1, factors thought relevant to
atherosclerosis, is constitutive, is constant, and can
be reduced only by dietary -3 fatty acids in unstimulated and
adherence-activated monocytes.
Key Words: mRNA • platelet-derived growth factor • monocyte chemoattractant protein-1 • interleukin-10 • heparin-bound epidermal growth factor
This article has been cited by other articles:
 |
|
 |
|
  D. L. Waitzberg and R. S. Torrinhas Fish Oil Lipid Emulsions and Immune Response: What Clinicians Need to Know Nutr Clin Pract, August 1, 2009; 24(4): 487 - 499. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. J. Jung, C. Torrejon, A. P Tighe, and R. J Deckelbaum n-3 Fatty acids and cardiovascular disease: mechanisms underlying beneficial effects Am. J. Clinical Nutrition, June 1, 2008; 87(6): 2003S - 2009S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. C. Calder Immunological Parameters: What Do They Mean? J. Nutr., March 1, 2007; 137(3): 773S - 780S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J Deckelbaum, T. S Worgall, and T. Seo n-3 Fatty acids and gene expression Am. J. Clinical Nutrition, June 1, 2006; 83(6): S1520 - 1525S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. S Kornman Interleukin 1 genetics, inflammatory mechanisms, and nutrigenetic opportunities to modulate diseases of aging Am. J. Clinical Nutrition, February 1, 2006; 83(2): 475S - 483S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Macchia, G. Levantesi, M. G. Franzosi, E. Geraci, A. P. Maggioni, R. Marfisi, G. L. Nicolosi, C. Schweiger, L. Tavazzi, G. Tognoni, et al. Left ventricular systolic dysfunction, total mortality, and sudden death in patients with myocardial infarction treated with n-3 polyunsaturated fatty acids Eur J Heart Fail, August 1, 2005; 7(5): 904 - 909. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Angerer, W. Kothny, S. Stork, and C. von Schacky Effect of dietary supplementation with {omega}-3 fatty acids on progression of atherosclerosis in carotid arteries Cardiovasc Res, April 1, 2002; 54(1): 183 - 190. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Stork, K. Baumann, C. von Schacky, and P. Angerer The effect of 17{beta}-estradiol on MCP-1 serum levels in postmenopausal women Cardiovasc Res, February 15, 2002; 53(3): 642 - 649. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. von Schacky n-3 Fatty acids and the prevention of coronary atherosclerosis1 Am. J. Clinical Nutrition, January 1, 2000; 71(1): 224S - 227S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. von Schacky, P. Angerer, W. Kothny, K. Theisen, and H. Mudra The Effect of Dietary {omega}-3 Fatty Acids on Coronary Atherosclerosis: A Randomized, Double-Blind, Placebo-Controlled Trial Ann Intern Med, April 6, 1999; 130(7): 554 - 562. [Abstract] [Full Text] [PDF]
|
|